MoonLake Immunotherapeutics (MLTX) shares were up more than 3% in Monday trading after Wolfe Research upgraded the stock to outperform from underperform, and lifted its price target to $24 from $12.
Trading volume stood at over 571,000 shares versus the daily average of 2 million.
Price: 16.81, Change: +0.54, Percent Change: +3.32